Compound Description
| ID: C0180 | Common name: Levofloxacin |
| IUPAC: NA | CAS: CAS:100986-85-4 |
| Chembl ID: CHEMBL33 | Pubchem ID: CID:149096 |
| Formula: C18H20FN3O4 | TCM-ID: TCMC1475 |
| Smiles: CN1CCN(CC1)c1c(F)cc2c3c1OC[C@@H](n3cc(c2=O)C(=O)O)C | |
| Alias:
7H-Pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid, 9-fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-, (S)-;
(3S)-9-Fluoro-2,3-dihydro-3-methyl-10-(4-methyl-1-piperazinyl)-7-oxo-7H-pyrido[1,2,3-de]-1,4-benzoxazine-6-carboxylic acid; (-)-Ofloxacin; (S)-(-)-Ofloxacin; (S)-Ofloxacin; Cravit; DR 3355; HR 355; Iquix; Levaquin; Levoflox; Levofloxacin; Lexoflon; Loxof; MP 376; Oftaquix; Quixin; RWJ 25213-097; Tavanic; Unibiotic; Venaxan |
Structure:
|
Related Targets (Total: 2)
| Target id | Protein Name | Gene Symbol | Uniprot ID | Target Level | No.of Literature Evidence |
|---|---|---|---|---|---|
| T96G89 | Fatty acid-binding protein, adipocyte | FABP4 |
P15090 |
A | 1 Reference(s) |
| T85U8U | Caspase-3 | CASP3 |
P42574 |
C | 1 Reference(s) |
*In this table, target level represents the quality confidence indicators of targets.
Level 'A' represents "Directly inhibit/activate".
Level 'B' represents "Indirectly inhibit/ activate", "Enzyme substate" and "Enzyme product".
Level 'C' represents "Up/Down regulation" and "Others".
Level 'A' represents "Directly inhibit/activate".
Level 'B' represents "Indirectly inhibit/ activate", "Enzyme substate" and "Enzyme product".
Level 'C' represents "Up/Down regulation" and "Others".
Related Herbs (Total: 2)
Ckey description of the interaction between compound and target